Cargando…

Analysis of tumor vascularization in a mouse model of metastatic lung cancer

Therapies targeting tumor vasculature would improve the treatment of lung metastasis, although the early changes in vascular structure are incompletely understood. Here, we show that obstructive metastatic foci in lung arterioles decrease the pulmonary vascular network. To generate a mouse model of...

Descripción completa

Detalles Bibliográficos
Autores principales: Sukhbaatar, Ariunbuyan, Sakamoto, Maya, Mori, Shiro, Kodama, Tetsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831815/
https://www.ncbi.nlm.nih.gov/pubmed/31690726
http://dx.doi.org/10.1038/s41598-019-52144-2
_version_ 1783466057202139136
author Sukhbaatar, Ariunbuyan
Sakamoto, Maya
Mori, Shiro
Kodama, Tetsuya
author_facet Sukhbaatar, Ariunbuyan
Sakamoto, Maya
Mori, Shiro
Kodama, Tetsuya
author_sort Sukhbaatar, Ariunbuyan
collection PubMed
description Therapies targeting tumor vasculature would improve the treatment of lung metastasis, although the early changes in vascular structure are incompletely understood. Here, we show that obstructive metastatic foci in lung arterioles decrease the pulmonary vascular network. To generate a mouse model of lung metastasis activation, luciferase-expressing tumor cells were inoculated into the subiliac lymph node (SiLN) of an MXH10/Mo-lpr/lpr mouse, and metastatic tumor cells in the lungs were activated by SiLN resection. Activation of metastases was monitored by in vivo bioluminescence imaging. Pulmonary blood vessel characteristics were analyzed using ex vivo micro-computed tomography. The enhanced permeability and retention (EPR) effect in neovasculature after tumor cell activation was evaluated from the accumulation of intravenously injected indocyanine green (ICG) liposomes. Metastatic foci in lung arterioles were investigated histologically. Micro-computed tomography revealed decreases in pulmonary blood vessel length, volume and number of branching nodes during the early stage of metastasis caused by metastatic foci. ICG liposome accumulation by the EPR effect was not detected. Histology identified metastatic foci in lung arterioles. The lack of an EPR effect after the formation of metastatic foci in lung arterioles makes conventional systemic chemotherapy ineffective for lung metastasis. Thus, alternative therapeutic methods of drug delivery are needed.
format Online
Article
Text
id pubmed-6831815
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-68318152019-11-13 Analysis of tumor vascularization in a mouse model of metastatic lung cancer Sukhbaatar, Ariunbuyan Sakamoto, Maya Mori, Shiro Kodama, Tetsuya Sci Rep Article Therapies targeting tumor vasculature would improve the treatment of lung metastasis, although the early changes in vascular structure are incompletely understood. Here, we show that obstructive metastatic foci in lung arterioles decrease the pulmonary vascular network. To generate a mouse model of lung metastasis activation, luciferase-expressing tumor cells were inoculated into the subiliac lymph node (SiLN) of an MXH10/Mo-lpr/lpr mouse, and metastatic tumor cells in the lungs were activated by SiLN resection. Activation of metastases was monitored by in vivo bioluminescence imaging. Pulmonary blood vessel characteristics were analyzed using ex vivo micro-computed tomography. The enhanced permeability and retention (EPR) effect in neovasculature after tumor cell activation was evaluated from the accumulation of intravenously injected indocyanine green (ICG) liposomes. Metastatic foci in lung arterioles were investigated histologically. Micro-computed tomography revealed decreases in pulmonary blood vessel length, volume and number of branching nodes during the early stage of metastasis caused by metastatic foci. ICG liposome accumulation by the EPR effect was not detected. Histology identified metastatic foci in lung arterioles. The lack of an EPR effect after the formation of metastatic foci in lung arterioles makes conventional systemic chemotherapy ineffective for lung metastasis. Thus, alternative therapeutic methods of drug delivery are needed. Nature Publishing Group UK 2019-11-05 /pmc/articles/PMC6831815/ /pubmed/31690726 http://dx.doi.org/10.1038/s41598-019-52144-2 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Sukhbaatar, Ariunbuyan
Sakamoto, Maya
Mori, Shiro
Kodama, Tetsuya
Analysis of tumor vascularization in a mouse model of metastatic lung cancer
title Analysis of tumor vascularization in a mouse model of metastatic lung cancer
title_full Analysis of tumor vascularization in a mouse model of metastatic lung cancer
title_fullStr Analysis of tumor vascularization in a mouse model of metastatic lung cancer
title_full_unstemmed Analysis of tumor vascularization in a mouse model of metastatic lung cancer
title_short Analysis of tumor vascularization in a mouse model of metastatic lung cancer
title_sort analysis of tumor vascularization in a mouse model of metastatic lung cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831815/
https://www.ncbi.nlm.nih.gov/pubmed/31690726
http://dx.doi.org/10.1038/s41598-019-52144-2
work_keys_str_mv AT sukhbaatarariunbuyan analysisoftumorvascularizationinamousemodelofmetastaticlungcancer
AT sakamotomaya analysisoftumorvascularizationinamousemodelofmetastaticlungcancer
AT morishiro analysisoftumorvascularizationinamousemodelofmetastaticlungcancer
AT kodamatetsuya analysisoftumorvascularizationinamousemodelofmetastaticlungcancer